Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, today ...

The Vexev and U.S. Renal Care teams successfully completed enrollment in the CANSCAN trial. The study is evaluating the use ...

Vexev announced today that it completed enrollment in a clinical trial evaluating its semi-autonomous ultrasound scanning technology.

Itching is often the most debilitating cutaneous symptom of CKD and ESRD. Experts recommend a stepwise treatment approach ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

Identifying early predictors of chronic kidney disease (CKD) progression in patients with lupus nephritis may help define a high-risk group.

Certain urine biomarkers may noninvasively assess kidney health in patients with diabetic kidney disease and help identify ...

Chronic kidney disease doesn’t always cause constipation, but there are a number of reasons why it does for many people. Learn about potential causes and treatment.

Exposure-response association seen between trihalomethanes and CKD risk; highest risk seen for brominated trihalomethanes.

Nursing care plans for CKD help monitor and manage disease progression by providing guidelines for identifying and resolving kidney-related issues. Learn more.